Literature DB >> 17380316

Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator-activator receptor gamma gene expression in macrophages.

J Graessler1, J Pietzsch, T Westendorf, U Julius, S R Bornstein, S Kopprasch.   

Abstract

AIMS/HYPOTHESIS: Glycoxidised LDL has been implicated in the pathogenesis of atherosclerosis, a major complication of diabetes. Since atherogenesis may occur at an early stage of diabetes, we investigated whether circulating LDL isolated from subjects with IGT (n = 20) showed an increased glycoxidation status and explored the proatherogenic effects of LDL samples on macrophages. SUBJECTS AND METHODS: We investigated LDL modifications using GC-MS. Murine macrophages were incubated with LDL samples for 1 h, and then mRNA expression rates of the scavenger receptors CD36 and scavenger receptor class B type 1 (SCARB1, formerly known as SR-BI) and transcription factor peroxisome proliferator-activator receptor gamma (PPARgamma) were quantified by real-time RT-PCR.
RESULTS: The GC-MS experiments revealed that oxidative modifications of proline, arginine, lysine and tyrosine residues in apolipoprotein B100 were three- to fivefold higher in LDL samples from IGT subjects compared with those from NGT subjects (n = 20). Moreover, LDL glycoxidation estimated by both Nepsilon-(carboxymethyl)lysine (CML) and Nepsilon-(carboxyethyl)lysine (CEL) residues was increased more than ninefold in LDL from IGT subjects compared with samples from NGT subjects. Compared with NGT LDL, IGT LDL elicited a significantly higher CD36 (p < 0.05) and PPARG (p < 0.05) gene expression, whereas SCARB1 mRNA expression was not affected. CONCLUSIONS/
INTERPRETATION: These data suggest that IGT is associated with increased glycoxidation of circulating LDL, which might contribute to the conversion of macrophages into a proatherogenic phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380316     DOI: 10.1007/s00125-007-0645-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  41 in total

1.  Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I.

Authors:  J Han; A C Nicholson; X Zhou; J Feng; A M Gotto; D P Hajjar
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

2.  In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance.

Authors:  Steffi Kopprasch; Jens Pietzsch; Eberhard Kuhlisch; Katja Fuecker; Theodora Temelkova-Kurktschiev; Markolf Hanefeld; Helmut Kühne; Ulrich Julius; Jürgen Graessler
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

3.  CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.

Authors:  G Chinetti; F G Gbaguidi; S Griglio; Z Mallat; M Antonucci; P Poulain; J Chapman; J C Fruchart; A Tedgui; J Najib-Fruchart; B Staels
Journal:  Circulation       Date:  2000-05-23       Impact factor: 29.690

4.  Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma.

Authors:  K H Han; M K Chang; A Boullier; S R Green; A Li; C K Glass; O Quehenberger
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

5.  Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages.

Authors:  T Nakagawa; S Nozaki; M Nishida; J M Yakub; Y Tomiyama; A Nakata; K Matsumoto; T Funahashi; K Kameda-Takemura; Y Kurata; S Yamashita; Y Matsuzawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-08       Impact factor: 8.311

6.  Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells.

Authors:  B E Brown; R T Dean; M J Davies
Journal:  Diabetologia       Date:  2005-01-20       Impact factor: 10.122

7.  A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.

Authors:  A Chawla; W A Boisvert; C H Lee; B A Laffitte; Y Barak; S B Joseph; D Liao; L Nagy; P A Edwards; L K Curtiss; R M Evans; P Tontonoz
Journal:  Mol Cell       Date:  2001-01       Impact factor: 17.970

Review 8.  Hyperglycemia, lipoprotein glycation, and vascular disease.

Authors:  Arvindan Veiraiah
Journal:  Angiology       Date:  2005 Jul-Aug       Impact factor: 3.619

Review 9.  Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling.

Authors:  Andrew C Nicholson
Journal:  Trends Cardiovasc Med       Date:  2004-01       Impact factor: 6.677

10.  Production of N(epsilon)-(carboxymethyl)lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation.

Authors:  Melissa M Anderson; Jay W Heinecke
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

View more
  3 in total

1.  Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways.

Authors:  Sarama Saha; Juergen Graessler; Peter E H Schwarz; Claudia Goettsch; Stefan R Bornstein; Steffi Kopprasch
Journal:  Mol Cell Biochem       Date:  2012-03-01       Impact factor: 3.396

2.  Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI.

Authors:  Sarama Saha; Juergen Graessler; Stefan R Bornstein; Peter E H Schwarz; Steffi Kopprasch
Journal:  Mol Cell Biochem       Date:  2013-07-14       Impact factor: 3.396

3.  Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinity.

Authors:  Christoph Tondera; Markus Laube; Jens Pietzsch
Journal:  Amino Acids       Date:  2016-10-12       Impact factor: 3.520

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.